641
Participants
Start Date
October 10, 2024
Primary Completion Date
May 31, 2027
Study Completion Date
June 15, 2027
IPN10200
Lyophilised powder
Placebo
Excipients without active substance, Lyophilised powder
IPN10200 dose A
Lyophilised powder
IPN10200 dose B
Lyophilised powder
RECRUITING
Montefiore Medical Center: Headache Center, The Bronx
RECRUITING
Integrative Clinical Trials, LLC, Brooklyn
RECRUITING
Upstate Clinical Research Associates, Williamsville
RECRUITING
Preferred Primary Care Physicians - Curry Hollow, Pittsburgh
RECRUITING
MedStar Neurosciences and Rehabilitation Research Network, Baltimore
NOT_YET_RECRUITING
MedStar Neurosciences and Rehabilitation, Baltimore
RECRUITING
MedStar Franklin Square Hospital Center, Baltimore
RECRUITING
M3 Wake Research/MSRA, LLC, Lake City
RECRUITING
Clinical Neuroscience Solutions, Inc - Memphis, Memphis
RECRUITING
Neurology Diagnostics, Inc., Dayton
RECRUITING
Michigan Head Pain & Neurological Institute, Ann Arbor
RECRUITING
Crescent City Headache and Neurology Center, LLC, Chalmette
RECRUITING
DelRicht Research at Touro Medical Center, New Orleans
RECRUITING
LSU Healthcare Network Orthopedic & Sports Medicine, New Orleans
RECRUITING
Advanced Neuroscience Research Center, LLC, Fort Collins
RECRUITING
MD First Research - Chandler, Chandler
RECRUITING
Pharmacology Research Institute (PRI), Los Alamitos
RECRUITING
Profound Research, LLC, Pasadena
RECRUITING
WR-PRI Encino, Encino
RECRUITING
Clinical Trials Management LLC, Thousand Oaks
RECRUITING
Profound Research. LLC - NCSC, Carlsbad
RECRUITING
Neuro-Pain Medical Center, Fresno
RECRUITING
Puget Sound Neurology - Neurology, Tacoma
Lead Sponsor
Ipsen
INDUSTRY